Michael L. Baur - 14 Nov 2024 Form 4 Insider Report for SCANSOURCE, INC. (SCSC)

Role
CEO & Chairman of the Board, Director
Signature
J. Creighton Lynes, attorney-in-fact
Issuer symbol
SCSC
Transactions as of
14 Nov 2024
Net transactions value
-$1,716,543
Form type
4
Filing time
18 Nov 2024, 20:00:04 UTC
Previous filing
04 Sep 2024
Next filing
21 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCSC Common Stock Options Exercise $34,552 +1,400 +0.79% $24.68 179,160 14 Nov 2024 Direct F1
transaction SCSC Common Stock Sale $68,474 -1,400 -0.78% $48.91 177,760 14 Nov 2024 Direct F1, F2
transaction SCSC Common Stock Options Exercise $696,396 +28,217 +16% $24.68 205,977 14 Nov 2024 Direct F1
transaction SCSC Common Stock Sale $1,388,559 -28,217 -14% $49.21 177,760 14 Nov 2024 Direct F1, F3
transaction SCSC Common Stock Options Exercise $624,453 +25,302 +14% $24.68 203,062 15 Nov 2024 Direct F1
transaction SCSC Common Stock Sale $1,239,545 -25,302 -12% $48.99 177,760 15 Nov 2024 Direct F1, F4
transaction SCSC Common Stock Options Exercise $372,199 +15,081 +8.5% $24.68 192,841 18 Nov 2024 Direct F1
transaction SCSC Common Stock Sale $747,565 -15,081 -7.8% $49.57 177,760 18 Nov 2024 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCSC Employee Stock Option (Right to Buy) Options Exercise $0 -29,617 -22% $0.000000 104,282 14 Nov 2024 Common Stock 29,617 $24.68 Direct F1, F6
transaction SCSC Employee Stock Option (Right to Buy) Options Exercise $0 -25,302 -24% $0.000000 78,980 15 Nov 2024 Common Stock 25,302 $24.68 Direct F1, F6
transaction SCSC Employee Stock Option (Right to Buy) Options Exercise $0 -15,081 -19% $0.000000 63,899 18 Nov 2024 Common Stock 15,081 $24.68 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions covered by this Form 4 have been effected pursuant to a Rule 10b5-1 Sales Plan adopted by the reporting person on September 1, 2023.
F2 The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $48.87 to $48.97 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.99 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $48.49 to $49.49 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $49.14 to $50.01 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The option vested in one-third increments on the anniversary of the grant date on 11/19/2021, 11/19/2022 and 11/19/2023.